Acurx Pharmaceuticals, Inc. (ACXP)
1.64
+0.03
(+1.86%)
USD |
NASDAQ |
Jun 10, 14:41
Acurx Pharmaceuticals SG&A Expense (Quarterly) : 1.374M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | 48.80M |
| Kala Bio, Inc. | 1.741M |
| Sensei Biotherapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |